High calcium scores are commonly considered a risk factor for coronary stenosis, but even a zero calcium score doesn’t assure coronary health in a high-risk population, concluded a pair of studies presented at ECR 2009.
High calcium scores are commonly considered a risk factor for coronary stenosis, but even a zero calcium score doesn’t assure coronary health in a high-risk population, concluded a pair of studies presented at ECR 2009.
Researchers from the Netherlands and China compared calcium scores against coronary stenosis in a high-risk population. In both studies, high calcium scores generally correlated with coronary stenosis.
In a small subset, however, zero calcium scores did not assure the absence of coronary stenosis.
A study from the University Medical Center Groningen in the Netherlands found that patients with a zero coronary score had a 93% chance of not having coronary stenosis but could not rule out stenosis when the pretest probability was high.
The study included 160 patients. Most (96) were admitted for chest pain. The remaining 64 were considered to have a high cardiovascular risk profile.
Among the study set, 43 had zero calcium scores. CT angiography scans found that three of the 43 (7%) had significant stenosis.
The study also showed that patients without stenosis on CTA had a mean calcium score of 109 (Agatston scale). Those with one or more signs of stenosis on CTA had a mean calcium score of 1030.
The distribution of calcium scores was the following:
• zero, 37%
• 10 to 100, 13%
• 101 to 400, 18%
• more than 400, 36%
A study from Tuen Mun Hospital in Hong Kong examined 147 patients admitted for chest pain. Sixty-eight had zero calcium scores. Among those, four (5.9%) had significant stenosis on CTA angiography. Another four had mild stenosis on CTA.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.